SENTINEL Trademark

Trademark Overview


On Friday, October 17, 2025, a trademark application was filed for SENTINEL with the United States Patent and Trademark Office. The USPTO has given the SENTINEL trademark a serial number of 99448480. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, February 12, 2026. This trademark is owned by Sequence LifeScience, Inc.. The SENTINEL trademark is filed in the Pharmaceutical Products category with the following description:

human allograft tissue
sentinel

General Information


Serial Number99448480
Word MarkSENTINEL
Filing DateFriday, October 17, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, February 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Serviceshuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSequence LifeScience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78249

Trademark Events


Event DateEvent Description
Friday, October 17, 2025NEW APPLICATION ENTERED
Friday, October 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 17, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, January 13, 2026ASSIGNED TO EXAMINER
Wednesday, January 14, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 14, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 14, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 11, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 11, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 11, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 12, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


sentinel tissue allograft human